CHECK CAP LTD (MBAI) Fundamental Analysis & Valuation

NASDAQ:MBAI • IL0011336851

Current stock price

1.68 USD
+0.03 (+1.82%)
At close:
1.7898 USD
+0.11 (+6.54%)
After Hours:

This MBAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MBAI Profitability Analysis

1.1 Basic Checks

  • MBAI had negative earnings in the past year.
  • MBAI had a positive operating cash flow in the past year.
  • In the past 5 years MBAI always reported negative net income.
  • MBAI had a negative operating cash flow in each of the past 5 years.
MBAI Yearly Net Income VS EBIT VS OCF VS FCFMBAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • The Return On Assets of MBAI (-436.31%) is worse than 95.74% of its industry peers.
  • MBAI has a worse Return On Equity (-668.32%) than 89.36% of its industry peers.
Industry RankSector Rank
ROA -436.31%
ROE -668.32%
ROIC N/A
ROA(3y)-2261.03%
ROA(5y)-1376.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBAI Yearly ROA, ROE, ROICMBAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • MBAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBAI Yearly Profit, Operating, Gross MarginsMBAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. MBAI Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MBAI has about the same amount of shares outstanding.
  • Compared to 5 years ago, MBAI has more shares outstanding
  • MBAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBAI Yearly Shares OutstandingMBAI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
MBAI Yearly Total Debt VS Total AssetsMBAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • MBAI has an Altman-Z score of -41.89. This is a bad value and indicates that MBAI is not financially healthy and even has some risk of bankruptcy.
  • MBAI's Altman-Z score of -41.89 is on the low side compared to the rest of the industry. MBAI is outperformed by 93.62% of its industry peers.
  • There is no outstanding debt for MBAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -41.89
ROIC/WACCN/A
WACCN/A
MBAI Yearly LT Debt VS Equity VS FCFMBAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • MBAI has a Current Ratio of 0.71. This is a bad value and indicates that MBAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MBAI has a Current ratio of 0.71. This is amonst the worse of the industry: MBAI underperforms 92.55% of its industry peers.
  • A Quick Ratio of 0.71 indicates that MBAI may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.71, MBAI is not doing good in the industry: 89.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
MBAI Yearly Current Assets VS Current LiabilitesMBAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

0

3. MBAI Growth Analysis

3.1 Past

  • The earnings per share for MBAI have decreased strongly by -43.15% in the last year.
EPS 1Y (TTM)-43.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%182.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y7.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBAI Yearly EPS VS EstimatesMBAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

1

4. MBAI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MBAI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBAI Price Earnings VS Forward Price EarningsMBAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBAI indicates a somewhat cheap valuation: MBAI is cheaper than 67.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 155.03
EV/EBITDA N/A
MBAI Per share dataMBAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. MBAI Dividend Analysis

5.1 Amount

  • No dividends for MBAI!.
Industry RankSector Rank
Dividend Yield 0%

MBAI Fundamentals: All Metrics, Ratios and Statistics

CHECK CAP LTD

NASDAQ:MBAI (4/10/2026, 8:00:01 PM)

After market: 1.7898 +0.11 (+6.54%)

1.68

+0.03 (+1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-30
Earnings (Next)N/A
Inst Owners0.54%
Inst Owner Change0%
Ins Owners4.94%
Ins Owner ChangeN/A
Market Cap12.25M
Revenue(TTM)N/A
Net Income(TTM)-25.15M
Analysts43.33
Price TargetN/A
Short Float %2.14%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 155.03
P/OCF 155.03
P/B 3.25
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-4.3
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)0.01
FCFY0.65%
OCF(TTM)0.01
OCFY0.65%
SpS0
BVpS0.52
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -436.31%
ROE -668.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2261.03%
ROA(5y)-1376.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z -41.89
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%182.59%
EPS Next Y7.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.44%
OCF growth 3YN/A
OCF growth 5YN/A

CHECK CAP LTD / MBAI Fundamental Analysis FAQ

What is the fundamental rating for MBAI stock?

ChartMill assigns a fundamental rating of 1 / 10 to MBAI.


What is the valuation status for MBAI stock?

ChartMill assigns a valuation rating of 1 / 10 to CHECK CAP LTD (MBAI). This can be considered as Overvalued.


How profitable is CHECK CAP LTD (MBAI) stock?

CHECK CAP LTD (MBAI) has a profitability rating of 0 / 10.


What is the expected EPS growth for CHECK CAP LTD (MBAI) stock?

The Earnings per Share (EPS) of CHECK CAP LTD (MBAI) is expected to grow by 7.34% in the next year.